MPI Research strives to be the best CRO in preclinical and early clinical contract research.

Read More

Lessons Learned in Preparing Nonclinical Programs Part IV

Watch Now

What are CROs and Pharma talking about?

Read More

MPI Research Adds Two to Pathology Team; Extends Position as Leader

We are committed to bring safer and more effective drugs and devices to the market faster and more efficiently.

With over 32,000 studies and counting and high satisfaction, MPI Research aims to be the CRO partner for your drug and device programs.

We partner with Sponsors around the world to develop their drug and device programs. Every year, our experienced scientists and dedicated technical team conduct thousands of discovery, drug safety, bioanalytical, analytical, medical device, and clinical research studies.

Submit Inquiry
IND-enabling Packages
Conducted Annually
People Dedicated to
Improving Healthcare

Lessons Learned in Preparing Nonclinical Programs Part II:

Species Selection The basic question that helps to address this is “what is your test article type?”.  For small [...]

Hernia Treatment Evaluation

With more than one million hernia repairs performed each year in the U.S., a hernia is an all-too common condition [...]

The Role of Biofilms in Infected Wounds

Anton van Leeuwenhoek (1632-1723) was the first person to delve into the field of microbiology and document initial observations of [...]

“MPI Research was very impressive, perhaps one of the best CROs I’ve seen! This company is proof that proper procedures and systems can be put in place for compliance; they have all the key SOPs and systems in place (and then some) that I look for. I only wish that I could take MPI Research with me as an example for other companies and CROs. The personnel were very helpful and knowledgeable; I would recommend this company to any one of my clients needing these services.”

Denise Carpenter,
Owner and President D.A. Carpenter Consulting, Inc.

“I was very impressed with the MPI Research team’s care in animal handling and their established enrichment programs for our various carcinogenicity studies. I continue to share the excellence of their animal care programs with our partners and other CROs. I would like to thank all the team members involved in our studies for taking such great care of the animals.”

Executive Director,
Pharmaceutical Company

“We have developed an extremely productive partnership with MPI Research over the past several years. Through the many immunology, pharmacokinetic, and general toxicology studies we have conducted at MPI Research, we have received quality, on-time data that has allowed us to progress our compounds along the drug development pathway. We trust and appreciate the commitment to excellence and dedication of MPI Research and we look forward to expanding our partnership.”

Chief Scientific Officer,
Biotechnology Company

Let us take you further